Cite
MLA Citation
Gelareh Zadeh et al.. “ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192).” Neuro-oncology, vol. 20, n.d., p. vi6. http://access.bl.uk/ark:/81055/vdc_100095488594.0x00001a